Home › Funds › Catalio Capital Management, LP › AXSM
Catalio Capital Management, LP position in AXSM
AXSOME THERAPEUTICS INC. · Health Care
Catalio Capital Management, LP reported holding 43,182 shares of AXSM (AXSOME THERAPEUTICS INC.) in its Q2 2026 13F filing — a position valued at US$10.6M, representing 1.99% of its reported portfolio and ranking #19 among its reported holdings. Catalio Capital Management, LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Catalio Capital Management, LP's AXSM position evolved
Catalio Capital Management, LP first disclosed a stake in AXSM in Q2 2026 at 43,182 shares (US$10.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 43.18K | $10.57M | New |
About AXSM and 13F data
AXSM (AXSOME THERAPEUTICS INC.) is a Health Care company. 54 other funds we track also report a position in AXSM — the largest reported positions include Deep Track Capital, LP (US$171.3M), ALETHEA CAPITAL MANAGEMENT, LLC (US$158.8M), Hood River Capital Management LLC (US$98.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AXSM
- Deep Track Capital, LP 700.00K sh · $171.34M · Q2 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 648.76K sh · $158.80M · Q2 2026
- Hood River Capital Management LLC 402.68K sh · $98.56M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 316.82K sh · $77.53M · Q2 2026
- Integral Health Asset Management, LLC 300.00K sh · $73.43M · Q2 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 254.28K sh · $62.24M · Q2 2026
- SAMLYN CAPITAL, LLC 246.01K sh · $60.22M · Q2 2026
- PFM Health Sciences, LP 219.60K sh · $53.75M · Q2 2026
- Tri Locum Partners LP 219.31K sh · $53.68M · Q2 2026
- First Turn Management, LLC 218.41K sh · $53.46M · Q2 2026
More on Catalio Capital Management, LP
FAQ
How long has Catalio Capital Management, LP held AXSM?
Catalio Capital Management, LP has disclosed AXSM holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Catalio Capital Management, LP's current position in AXSM?
As of Q2 2026, Catalio Capital Management, LP holds 43.18K shares of AXSM (AXSOME THERAPEUTICS INC.), valued at $10.57M, representing 1.99% of its reported portfolio and ranking #19.
Has Catalio Capital Management, LP been buying or selling AXSM?
In the latest 13F filing (Q2 2026), Catalio Capital Management, LP newly opened its position in AXSM.
Which other funds hold AXSM?
Other major institutional holders of AXSM include Deep Track Capital, LP, ALETHEA CAPITAL MANAGEMENT, LLC, Hood River Capital Management LLC, among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.